Find your next paid study

Boston University Charles River CampusNCT06736522

Actual pay is set by the research site.

Tissue Procurement and Outcome Collection for Radiotherapy Treated Patients and Healthy Participants

RATIONALE: Collecting and storing samples of tissue from patients with cancer to test in the laboratory may help the study of cancer in the future. PURPOSE: T…

Unspecified Adult Solid Tumor, Protocol Specific

University of Texas Southwestern Medical CenterNCT00992303

Actual pay is set by the research site.

AngiosarcomaAngiosarcoma, Adult

An Open-Label, Multicenter, Phase 2 Study With Safety Lead-In of Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab in Patients With Angiosarcoma

This is a multicenter, open-label study of Intratumoral Vusolimogene Oderparepvec (VO) to investigate safety and estimate when used in combination with pembrol…

Varun Monga, MBBSNCT06898970

~$75 – $3,000

Actual pay is set by the research site.

Bladder Squamous Cell CarcinomaLocally Advanced Bladder CarcinomaMalignant Renal Pelvis Neoplasm+8 more

Phase II Single-Arm Study of Enfortumab Vedotin (EV) Plus Pembrolizumab in the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology

This phase II trial tests how well enfortumab vedotin (EV) and pembrolizumab works in treating patients with bladder cancer of variant histology (a group of le…

Emory UniversityNCT05756569

~$75 – $2,000

Actual pay is set by the research site.

Observational

Biomarkers for Peripheral Circadian Clocks in Humans

The purpose of this project is to improve our understanding of peripheral circadian rhythms in humans. Circadian clocks are present in most tissues of the body…

Circadian Rhythms

University of Colorado, BoulderNCT06296823

Actual pay is set by the research site.

Phase 1

A Phase 1/2a, Multicenter, Open-Label, First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1310 in Subjects With Advanced/Metastatic Solid Tumors

This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1310 in subjects with advanced solid tumors.

Advanced Solid Tumor

DualityBio Inc.NCT05785741

~$150 – $4,200

Actual pay is set by the research site.

Gastroesophageal Junction AdenocarcinomaEsophagogastric Cancer

A Phase II Study of Neoadjuvant NAPOX Followed by Chemoradiation With Paclitaxel and Carboplatin in Locally Advanced Esophagogastric Cancer

In this research study, is studying how Liposomal Irinotecan in combination with the standard of care interventions FOLFOX, carboplatin paclitaxel, and radiati…

Massachusetts General HospitalNCT04656041

~$75 – $2,000

Actual pay is set by the research site.

Phase 1

Phase I/II Study of Ladarixin and Sotorasib in Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer (NSCLC)

This is a phase I/II, open-label, study of twice-daily oral ladarixin with sotorasib in participants with advanced KRASG12C mutant non-small cell lung cancer (…

Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation

NYU Langone HealthNCT05815173

~$150 – $4,500

Actual pay is set by the research site.

Observational

Hydration Intervention to Address Dehydration Associated With Use of GLP-1 Based Medications

This is a 17 - week study consisting of a one - week run - in period and a 16 - week intervention. The 16 - week pilot interventions aims to increase hydration…

Obesity & OverweightType 2 DiabetesType 2 Diabetes (Adult Onset)+2 more

State University of New York at BuffaloNCT07641361

Actual pay is set by the research site.

Observational

Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Heterogeneity in ADHD

Attention deficit/hyperactivity disorder (ADHD) can present differently in individuals, with some individuals having difficulty with attentional control, hyper…

Attention Deficit Hyperactivity Disorder (ADHD)SleepPhysical Activity

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.NCT06810180

~$10 – $1,050

Actual pay is set by the research site.

Head and Neck Squamous Cell CarcinomaHead and Neck CancerResectable Head and Neck Squamous Cell Carcinoma+2 more

A Phase 2 Study of Preoperative Pembrolizumab and Chemotherapy Followed by Adjuvant Pembrolizumab in Resectable Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma

This research study is evaluating effectiveness and safety of a combination of immunotherapy drug, pembrolizumab, with chemotherapy, as a possible treatment be…

Dana-Farber Cancer InstituteNCT05726370

~$75 – $3,000

Actual pay is set by the research site.

HNSCCHead and Neck Squamous Cell Carcinoma

Single-Center Evaluation of the Clinical and Radiological Benefit of AHCC® in Combination with Standard of Care Treatment for HPV-Positive Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)

This is a phase 2, single-arm, open-label clinical trial determining safety and tolerability of AHCC in subjects with HPV-positive patients with Head and Neck …